5 news items
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
PROK
10 Jun 24
be affected by, among other things, competition and the ability of the Company to grow and manage growth profitably and retain its key employees; the risk
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
PROK
21 May 24
and retain its key employees; the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
PROK
10 May 24
and retain its key employees; the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry; the inability
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
PROK
25 Mar 24
and retain its key employees; the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry; the inability
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
PROK
21 Mar 24
things, competition and the ability of the Company to grow and manage growth profitably and retain its key employees; the risk of downturns
- Prev
- 1
- Next